J Thorac Cardiovasc Surg. 2020 Aug;160(2):601-605. doi: 10.1016/j.jtcvs.2020.03.061. Epub 2020 Apr 9.
The extraordinary demands of managing the COVID-19 pandemic has disrupted the world's ability to care for patients with thoracic malignancies. As a hospital's COVID-19 population increases and hospital resources are depleted, the ability to provide surgical care is progressively restricted, forcing surgeons to prioritize among their cancer populations. Representatives from multiple cancer, surgical, and research organizations have come together to provide a guide for triaging patients with thoracic malignancies as the impact of COVID-19 evolves as each hospital.
管理 COVID-19 大流行的特殊要求扰乱了全球照顾胸恶性肿瘤患者的能力。随着医院 COVID-19 患者人数的增加和医院资源的枯竭，提供手术护理的能力逐渐受到限制，迫使外科医生在癌症患者中进行优先排序。来自多个癌症、外科和研究组织的代表齐聚一堂，为每个医院 COVID-19 不断变化的影响下胸恶性肿瘤患者的分诊提供指导。
